Author

T. Kitao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

H. Nagai· 3 shared T. Kubori· 3 shared A. Felici· 1 shared A. K. Pramono· 1 shared C. Pignaffo· 1 shared D. Andreotti· 1 shared D. Maura· 1 shared E. Calcaterra· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

H. Nagai

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Multi-tiered actions of Legionella effectors to modulate host Rab10 dynamics

T. Kubori, K. Arasaki, H. Oide, T. Kitao, H. Nagai

This study identifies how Legionella pneumophila effectors modulate Rab10 dynamics through ubiquitin signaling, phosphoribosylation, and crosslinking to control bacterial vacuole function.

bioRxiv · Jun 2, 2023 · PreprintMicrobiology

Mechanism of Lys6 poly-ubiquitin specificity by the L. pneumophila deubiquitinase LotA

G. D. Warren, T. Kitao, T. G. Franklin, J. V. Nguyen, P. P. Geurink, T. Kubori, H. Nagai, J. N. Pruneda

This study identifies and characterizes the deubiquitinase domain of LotA from L. pneumophila that specifically targets K6-linked poly-ubiquitin during infection.

bioRxiv · May 11, 2022Biochemistry

Tackling Recalcitrant Pseudomonas aeruginosa Infections In Critical Illness via Anti-virulence Monotherapy

V. K. SINGH, M. Almpani, D. Maura, T. Kitao, L. Ferrari, S. Fontana, G. Bergamini, E. Calcaterra, C. Pignaffo, M. Negri, T. d. Oliveira Pereira, F. Skinner, M. Gkikas, D. Andreotti, A. Felici, , L. G. Rahme

This study identifies novel anti-MvfR compounds (NAMs) that reduce intestinal permeability and inflammation in Pseudomonas aeruginosa infections, offering a potential monotherapy for critical illness.

bioRxiv · Apr 27, 2022Microbiology

Isolation and characterization of a novel phage SaGU1 that infects Staphylococcus aureus clinical isolates from patients with atopic dermatitis

Y. Shimamori, A. K. Pramono, T. Kitao, T. Suzuki, S.-i. Aizawa, T. Kubori, H. Nagai, S. Takeda, H. Ando

This study isolates and characterizes a novel phage SaGU1 that infects S. aureus clinical isolates from atopic dermatitis patients, showing it is safe and effective for phage therapy.

bioRxiv · Oct 24, 2020Microbiology